Ventricular Tachycardia Ablation Outcomes in Patients With Previous Implantable Cardioverter-Defibrillator Insertion:
Ali Saad Al-Shammari1,2, Ankur Singla3, Adishwar Rao4
1College of Medicine, University of Baghdad, Baghdad, Iraq.
Background:
Catheter ablation is increasingly used in patients with ventricular tachycardia (VT) and an implantable cardioverter-defibrillator (ICD) device in situ, but its real-world safety and effectiveness remain underexplored in this high-risk population. We aim to evaluate in-hospital outcomes associated with catheter ablation in VT patients with a history of ICD implantation using a large, nationally representative dataset.
Methods:
We performed a retrospective cohort study using the National Inpatient Sample (2016-2021) to identify adult hospitalizations with VT and prior ICD device insertion. Patients were stratified into ablation and non-ablation groups. Propensity score matching was used to balance baseline characteristics. Primary outcome was in-hospital mortality; secondary outcomes included acute heart failure, ST-elevation myocardial infarction (STEMI), sepsis, major adverse cardiac events (MACE), and procedure-related complications.
Results:
Among 395,290 hospitalizations with VT and prior ICD, 4.9% underwent ablation. Catheter ablation remained independently associated with reduced in-hospital mortality (adjusted odds ratio [aOR] = 0.59; 95% CI: 0.48-0.74), acute heart failure (aOR = 0.59; 95% CI: 0.54-0.64), ST-elevation MI (aOR = 0.44; 95% CI: 0.36-0.54), and sepsis (aOR = 0.34; 95% CI: 0.26-0.45) (all p < 0.001). The composite MACE outcome also showed a reduced odds ratio for ablation (aOR = 0.76; 95% CI: 0.68-0.85; p < 0.001). However, ablation was also associated with higher odds of cardiac tamponade (aOR = 8.33; 95% CI: 5.92-11.73), cardiogenic shock (aOR = 1.36; 95% CI: 1.19-1.55), need for mechanical circulatory support (aOR = 5.36; 95% CI: 4.63-6.21), and prolonged hospital stay ≥ 7 days (aOR = 1.69; 95% CI: 1.57-1.82) (all p < 0.001).
Conclusion:
In patients with VT and prior ICD implantation, catheter ablation is associated with improved in-hospital outcomes but higher procedural risks. These findings support its selective use in experienced centers capable of managing complications.
More Related Videos
Related Concept Videos
02:24Predicting Reaction Outcomes
01:13Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
01:11Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
01:12Porin Insertion in the Outer Mitochondrial Membrane
Three models describe the assembly of porins by the SAM complex and their insertion into the outer membrane. Model 1 suggests that porins are assembled outside the SAM channel as the...
01:26Insertion of Single-pass Transmembrane Proteins in the RER
Integral transmembrane proteins possess transmembrane and extra membrane domains. The transmembrane domains are primarily made of 20-25 hydrophobic amino acids arranged in a helical secondary confirmation. These...